Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

Autor: Iqbal, S. *, Goldman, B., Fenoglio-Preiser, C.M., Lenz, H.J., Zhang, W., Danenberg, K.D., Shibata, S.I., Blanke, C.D.
Zdroj: In Annals of Oncology December 2011 22(12):2610-2615
Databáze: ScienceDirect